These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 7487135)
1. Proliferation and interferon-gamma receptor expression in psoriatic and healthy keratinocytes are influenced by interactions between keratinocytes and fibroblasts in a skin equivalent model. Fransson J; Emilson A; Scheynius A; Hammar H Arch Dermatol Res; 1995; 287(6):517-23. PubMed ID: 7487135 [TBL] [Abstract][Full Text] [Related]
2. The effect of IFN-gamma on healthy and psoriatic keratinocytes in a skin equivalent model is influenced by the source of the keratinocytes and by their interactions with fibroblasts. Fransson J; Shen Q; Scheynius A; Hammar H Arch Dermatol Res; 1996 Dec; 289(1):14-20. PubMed ID: 9017130 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of CD208 (DC-LAMP) in epidermal keratinocytes of psoriatic lesions. Higaki M; Higaki Y; Kawashima M J Dermatol; 2009 Mar; 36(3):144-9. PubMed ID: 19335688 [TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor-alpha does not influence proliferation and differentiation of healthy and psoriatic keratinocytes in a skin-equivalent model. Fransson J Acta Derm Venereol; 2000; 80(6):416-20. PubMed ID: 11243633 [TBL] [Abstract][Full Text] [Related]
5. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions. Nickoloff BJ; Mitra RS; Elder JT; Fisher GJ; Voorhees JJ Br J Dermatol; 1989 Aug; 121(2):161-74. PubMed ID: 2476168 [TBL] [Abstract][Full Text] [Related]
6. Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1/2 and GSK-3β. Chen JQ; Man XY; Li W; Zhou J; Landeck L; Cai SQ; Zheng M Cell Biochem Biophys; 2013 Jul; 66(3):523-8. PubMed ID: 23283814 [TBL] [Abstract][Full Text] [Related]
7. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha. Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400 [TBL] [Abstract][Full Text] [Related]
8. Immunohistopathologic studies in the development of psoriatic lesion influenced by gamma-interferon and the producing cells. Kaneko F; Suzuki M; Takiguchi Y; Itoh N; Minagawa T J Dermatol Sci; 1990 Nov; 1(6):425-34. PubMed ID: 2126953 [TBL] [Abstract][Full Text] [Related]
9. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes. Piepkorn M; Predd H; Underwood R; Cook P Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307 [TBL] [Abstract][Full Text] [Related]
10. Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis. Huang BB; Bonish BK; Chaturvedi V; Qin JZ; Nickoloff BJ J Invest Dermatol; 2001 Feb; 116(2):305-12. PubMed ID: 11180008 [TBL] [Abstract][Full Text] [Related]
11. Expression of tenascin-C splice variants by human skin cells. Latijnhouwers MA; de Jongh GJ; Bergers M; de Rooij MJ; Schalkwijk J Arch Dermatol Res; 2000 Sep; 292(9):446-54. PubMed ID: 11000288 [TBL] [Abstract][Full Text] [Related]
12. Response of keratinocytes from normal and psoriatic epidermis to interferon-gamma differs in the expression of zinc-alpha(2)-glycoprotein and cathepsin D. Chen SH; Arany I; Apisarnthanarax N; Rajaraman S; Tyring SK; Horikoshi T; Brysk H; Brysk MM FASEB J; 2000 Mar; 14(3):565-71. PubMed ID: 10698972 [TBL] [Abstract][Full Text] [Related]
13. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22. Honma M; Minami-Hori M; Takahashi H; Iizuka H J Dermatol Sci; 2012 Feb; 65(2):134-40. PubMed ID: 22189341 [TBL] [Abstract][Full Text] [Related]
14. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1. Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222 [TBL] [Abstract][Full Text] [Related]
16. Altered expression of keratinocyte growth factor and its receptor in psoriasis. Finch PW; Murphy F; Cardinale I; Krueger JG Am J Pathol; 1997 Dec; 151(6):1619-28. PubMed ID: 9403712 [TBL] [Abstract][Full Text] [Related]
17. An altered response by psoriatic keratinocytes to gamma interferon. Baker BS; Powles AV; Valdimarsson H; Fry L Scand J Immunol; 1988 Dec; 28(6):735-40. PubMed ID: 3148190 [TBL] [Abstract][Full Text] [Related]
18. Expression of interferon-gamma receptors in normal and psoriatic skin. Scheynius A; Fransson J; Johansson C; Hammar H; Baker B; Fry L; Valdimarsson H J Invest Dermatol; 1992 Feb; 98(2):255-8. PubMed ID: 1531061 [TBL] [Abstract][Full Text] [Related]
19. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin. Reichrath J; Müller SM; Kerber A; Baum HP; Bahmer FA J Am Acad Dermatol; 1997 Jan; 36(1):19-28. PubMed ID: 8996256 [TBL] [Abstract][Full Text] [Related]
20. Psoriatic keratinocytes show reduced IRF-1 and STAT-1alpha activation in response to gamma-IFN. Jackson M; Howie SE; Weller R; Sabin E; Hunter JA; McKenzie RC FASEB J; 1999 Mar; 13(3):495-502. PubMed ID: 10064616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]